Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana M Tari

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Clinical & Experimental Metastasis|December 30, 2008
Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cellsVanity McMurtry, Ann-Marie Simeone, René Nieves-Alicea, et al.
Breast Cancer Research and Treatment|April 4, 2008
Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expressionRené Nieves-Alicea, Nancy H Colburn, Ann-Marie Simeone, et al.
Seminars in Oncology|July 26, 2002
Bcl-2-related antisense therapyYolanda Gutiérrez-Puente, Pablo Zapata-Benavides, Ana M Tari, et al.
International Journal of Cancer|September 5, 2002
Cyclosporin A enhances the apoptotic effects of N-(4-hydroxyphenyl)retinamide in breast cancer cellsSoo-Jeong Lim, Ann-Marie Simeone, Chong-Kook Kim, et al.
Molecular Cancer Therapeutics|December 17, 2002
A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxideAnn-Marie Simeone, Suhendan Ekmekcioglu, Lyle D Broemeling, et al.
Oncology Reports|December 28, 2011
Programmed cell death 4 inhibits leptin-induced breast cancer cell invasionVianey González-Villasana, René Nieves-Alicea, Vanity McMurtry, et al.
Carcinogenesis|October 4, 2005
N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cellsAnn-Marie Simeone, Stefano Colella, Ralf Krahe, et al.
Clinical & Experimental Metastasis|January 28, 2005
KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2Xiao-Ping Zang, Doris R Siwak, Thi X Nguyen, et al.
Oncogene|August 1, 2002
Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cellsAna M Tari, Soo-Jeong Lim, Mien-Chie Hung, et al.
International Journal of Oncology|March 3, 2007
Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cellsAnn-Marie Simeone, Rene Nieves-Alicea, Vanity C McMurtry, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Clinical & Experimental Metastasis|December 30, 2008
Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cellsVanity McMurtry, Ann-Marie Simeone, René Nieves-Alicea, et al.
Breast Cancer Research and Treatment|April 4, 2008
Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expressionRené Nieves-Alicea, Nancy H Colburn, Ann-Marie Simeone, et al.
Seminars in Oncology|July 26, 2002
Bcl-2-related antisense therapyYolanda Gutiérrez-Puente, Pablo Zapata-Benavides, Ana M Tari, et al.
International Journal of Cancer|September 5, 2002
Cyclosporin A enhances the apoptotic effects of N-(4-hydroxyphenyl)retinamide in breast cancer cellsSoo-Jeong Lim, Ann-Marie Simeone, Chong-Kook Kim, et al.
Molecular Cancer Therapeutics|December 17, 2002
A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxideAnn-Marie Simeone, Suhendan Ekmekcioglu, Lyle D Broemeling, et al.
Oncology Reports|December 28, 2011
Programmed cell death 4 inhibits leptin-induced breast cancer cell invasionVianey González-Villasana, René Nieves-Alicea, Vanity McMurtry, et al.
Carcinogenesis|October 4, 2005
N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cellsAnn-Marie Simeone, Stefano Colella, Ralf Krahe, et al.
Clinical & Experimental Metastasis|January 28, 2005
KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2Xiao-Ping Zang, Doris R Siwak, Thi X Nguyen, et al.
Oncogene|August 1, 2002
Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cellsAna M Tari, Soo-Jeong Lim, Mien-Chie Hung, et al.
International Journal of Oncology|March 3, 2007
Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cellsAnn-Marie Simeone, Rene Nieves-Alicea, Vanity C McMurtry, et al.
Pageof 4